Eurocine Vaccines discloses year-end report for the fiscal year 2022/2023
Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the year-end report for the fiscal year 2022/2023. Below is a summary of the report. The full report is available on the Eurocine Vaccines website (Investors - Eurocine Vaccines ) and as an attachment. 2023-04-01 - 2023-06-30 (fourth quarter) · Results after tax for the quarter amounted to -3,1 MSEK (-5,2 MSEK) · Revenues for the quarter amounted to 0 KSEK (43 KSEK) · Earnings per share for the quarter amounted to -0,111 SEK (-0,302 SEK) 2022-07-01 - 2023-06-30 (